GL1X · GenesisL1 explorer

Research workbench

Vaccine-elicited murine fp-targeting antibody VFP25.18 in complex with HIV fusion peptide (residue 512-519)

Analyse Vaccine-elicited murine fp-targeting antibody VFP25.18 in complex with HIV… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6PDR
Type
protein
Length
439 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Antibody VFP25.18 light chain; Antibody VFP25.18 heavy chain; HIV fusion peptide residue…
Pockets
4 · best druggability 0.42

Structure

x-ray diffraction · 3 distinct chains · 6% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
LAntibody VFP25.18 light chainprotein2187% helix, 51% strand—
HAntibody VFP25.18 heavy chainprotein2136% helix, 55% strand—
AHIV fusion peptide residue 512-519protein80% helix, 13% strand—

Pockets

4 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11740.420.7332empty
21280.410.7524empty
31050.400.7624empty
4540.250.7316empty

Interfaces

3 interfaces between chains.

  • L–H · 1526 Ų buried · 13 hydrogen bonds · protein-protein
  • L–A · 370 Ų buried · 0 hydrogen bonds · protein-protein
  • H–A · 355 Ų buried · 7 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 6PDR · Vaccine-elicited murine FP-targeting antibody vFP25.18 in complex with HIV fusion peptide… · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.